US Patent Litigations are now available. Check here

Explore Abbisko Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 12, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3632907Feb 28, 2024N-(Azaaryl)Cyclolactam-1-Carboxamide Derivative, Preparation Method Therefor, And Use Thereof1